Cell Therapy Analytical Development Summit

Memo

Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, as we discuss how to robustly validate assays and advance the characterization of cell immunotherapy analytics to ensure safe, effective and quality cell therapy products. Navigate across 3 days packed with dedicated, interactive formats exploring standardization efforts and novel assays to develop the full analytical package for cell therapies. Prices:Pharma and Biotech Conference Only: USD 2099.0,Pharma and Biotech Conference + Workshop: USD 2498.0,Service Provider Conference Only: USD 2799.0,Service Provider Conference + Workshop: USD 3348.0,Academic Conference Only: USD 1799.0,Academic Conference + Workshop: USD 2148.0,EB discounted rates available : USD 600.0 Speakers: Farah Fawaz VP Quality Control Allogene Therapeutics, Xenia Naj Project Leader Cellectis, Francesco Marincola President and Chief Scientific Officer Refuge Biotechnologies, Barrett Nehilla Associate Director, Analytical Development/QC Repertoire Immune Medicines, Alessandra Cesano Chief Medical Officer- Consultant Essa Pharmaceuticals, Vladimir Senyukov Director, BioAnalytical Development Precision Biosciences Inc, Mamta Kalra Director, CMC Immatics US Inc, Petrina Georgala Fellow Scientist, Analytical Lead Technical Research and Development Novartis Pharmaceuticals, and more. Time: 9:00 am - 5:30 pm